Literature DB >> 2324272

Encapsulation of Staphylococcus aureus isolates from mastitic milk: relationship between capsular polysaccharide types 5 and 8 and colony morphology in serum-soft agar, clumping factor, teichoic acid, and protein A.

L Sutra1, C Mendolia, P Rainard, B Poutrel.   

Abstract

A total of 193 Staphylococcus aureus isolates from bovine, caprine, and ovine mastitis producing type 5 or 8 capsular polysaccharides were investigated for colony morphology in serum-soft agar and agglutinability by an anti-teichoic acid serum, after cultivation in modified staphylococcus medium no. 110. Also, 40 of these strains were cultivated in brain heart infusion and submitted to clumping factor and protein A detection tests. Considering capsular serotyping as a reference method, diffuse growth in serum-soft agar and inagglutinability by anti-teichoic acid serum identified, respectively, 57.5 and 45% of encapsulated strains cultivated in brain heart infusion and 85.5 and 77.2% of those cultivated in modified staphylococcus medium 110. Consequently, these indirect techniques underestimated encapsulation and were greatly influenced by culture conditions. Whatever the medium used, diffuse colony morphology in serum-soft agar was generally characterized by a masking of teichoic acid and protein A. By contrast, these surface antigens were detected in association with compact morphology; the presence of a thin or discontinuous capsular material could explain this result. Moreover, the masking of teichoic acid and the removal of capsular polysaccharide by washing in saline suggest that type 8 capsular polysaccharide is more abundant and labile than type 5.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324272      PMCID: PMC269641          DOI: 10.1128/jcm.28.3.447-451.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Encapsulated Staphylococcus aureus from bovine mastitis.

Authors:  J P Opdebeeck; D A O'Boyle; A J Frost
Journal:  Aust Vet J       Date:  1988-06       Impact factor: 1.281

2.  Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types.

Authors:  D Sompolinsky; Z Samra; W W Karakawa; W F Vann; R Schneerson; Z Malik
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

3.  The expression of capsule in serum-soft agar by Staphylococcus aureus isolated from bovine mastitis.

Authors:  J P Opdebeeck; A J Frost; D O'Boyle; N L Norcross
Journal:  Vet Microbiol       Date:  1987-03       Impact factor: 3.293

4.  Evaluation of three rapid tests for identification of Staphylococcus aureus isolated in bovine milk.

Authors:  B Poutrel; M Ducelliez
Journal:  Ann Rech Vet       Date:  1979

5.  Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  W W Karakawa; A Sutton; R Schneerson; A Karpas; W F Vann
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.

Authors:  J M Fournier; W F Vann; W W Karakawa
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Pseudocompact-type growth and conversion of growth types of strains of Staphylococcus aureus in vitro and in vivo.

Authors:  K Yoshida; M Takahashi; Y Takeuchi
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

8.  Mechanism of compact-colony formation by strains of Staphylococcus aureus in serum soft agar.

Authors:  K Yoshida; T Ohtomo; Y Minegishi
Journal:  J Gen Microbiol       Date:  1977-01

9.  Slime production by bovine milk Staphylococcus aureus and identification of coagulase-negative staphylococcal isolates.

Authors:  P N Rather; A P Davis; B J Wilkinson
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

10.  Relation of mucoid growth of Staphylococcus aureus to clumping factor reaction, morphology in serum-soft agar, and virulence.

Authors:  K Yoshida; R D Ekstedt
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

View more
  10 in total

1.  Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.

Authors:  B Dassy; J M Fournier
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.

Authors:  B Poutrel; F B Gilbert; M Lebrun
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

3.  A Shared noncapsular antigen is responsible for false-positive reactions by Staphylococcus epidermidis in commercial agglutination tests for Staphylococcus aureus.

Authors:  J E Blake; M A Metcalfe
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Phagocytosis of mastitis isolates of Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk.

Authors:  L Sutra; P Rainard; B Poutrel
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

5.  Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.

Authors:  Annette H Kampen; Tore Tollersrud; Arve Lund
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin.

Authors:  J A Leigh; T R Field
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.

Authors:  A I Fattom; J Sarwar; A Ortiz; R Naso
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.

Authors:  A Fattom; R Schneerson; D C Watson; W W Karakawa; D Fitzgerald; I Pastan; X Li; J Shiloach; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.609

10.  Antimicrobial activity of Enterococcus Faecium Fair-E 198 against gram-positive pathogens.

Authors:  Maristela da Silva do Nascimento; Izildinha Moreno; Arnaldo Yoshiteru Kuaye
Journal:  Braz J Microbiol       Date:  2010-03-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.